Keyphrases
Multicenter Clinical Trial
100%
Residual Renal Function
100%
Renal Replacement Therapy
100%
Incremental Hemodialysis
100%
Hemodialysis
60%
Thrice Weekly
60%
Clinical Trials
40%
Kidney Function
40%
Regular Hemodialysis
40%
Weekly Regimen
40%
Uremic Toxins
40%
Hospital Admission
20%
Quality of Life
20%
Nutritional Status
20%
Renal Transplant Recipients
20%
Hazard Ratio
20%
Survival Rate
20%
Potential Gains
20%
Confounding Factors
20%
Survival Analysis
20%
Conventional Treatment
20%
Kaplan-Meier Method
20%
Log-rank Test
20%
Anemia
20%
Proportional Hazards Model
20%
Clearance Rate
20%
Patient Recruitment
20%
Clinical Parameters
20%
Selection Bias
20%
Sufficient Follow-up
20%
Method Design
20%
Survival Curve
20%
High Survival
20%
Required Sample Size
20%
Acute Renal Failure
20%
Hospital Mortality
20%
Trial Registration
20%
Statistical Power
20%
Dialysis Dose
20%
Intention-to-treat Principle
20%
Mean Comparison
20%
Dose Control
20%
Open-label Clinical Trial
20%
January 2017
20%
Time-to-event Analysis
20%
Kidney Transplant Failure
20%
Medium Weight
20%
Uremic Patients
20%
Incident Hemodialysis Patients
20%
Dialysis Initiation
20%
Urea Clearance
20%
Medicine and Dentistry
Clinical Trial
100%
Kidney Function
100%
Hemodialysis
100%
Renal Replacement Therapy
100%
Observational Study
42%
Uremic Toxin
28%
Quality of Life
14%
Kidney Graft
14%
Nutritional Status
14%
Hazard Ratio
14%
Survival Rate
14%
Proportional Hazards Model
14%
Kaplan Meier Method
14%
Survival Analysis
14%
Log Rank Test
14%
Anemia
14%
Patient Recruitment
14%
Intention-to-Treat Analysis
14%
Selection Bias
14%
Acute Kidney Injury
14%
Nursing and Health Professions
Hemodialysis
100%
Renal Replacement Therapy
100%
Uremic Toxin
28%
Nutritional Status
14%
Hazard Ratio
14%
Quality of Life
14%
Sample Size
14%
Survival Analysis
14%
Anemia
14%
Survival Rate
14%
Confounding Factor
14%
Intention to Treat Analysis
14%
Kidney Graft
14%
Proportional Hazards Model
14%
Hospital Mortality
14%
Acute Kidney Failure
14%
Log Rank Test
14%
Kaplan Meier Method
14%
Pharmacology, Toxicology and Pharmaceutical Science
Clinical Trial
100%
Replacement Therapy
100%
Hemodialysis
100%
Observational Study
42%
Uremic Toxin
28%
Survival Rate
14%
Anemia
14%
Acute Kidney Failure
14%
Patient Recruitment
14%